Advent of PARP Inhibitors in Metastatic CRPC
Moving on to discuss metastatic castration-resistant prostate cancer, panelists highlight the evolving role of PARP inhibition in this setting.
Source: onclive.com
Page 2 - Germline Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Germline Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Germline Testing Today - Breaking & Trending Today
Understanding Lynch Syndrome and Associated Cancer Risk: Future Preventive Considerations
In this sixth episode of OncChats: Understanding Lynch Syndrome and Cancer Risk, Fay Kastrinos, MD, MPH, shares future considerations for optimizing the identification of Lynch syndrome and other efforts underway to prevent colorectal cancer in those who have this condition.
Source: onclive.com
New Research Insights to be Presented by Invitae at the 2023 ASCO Annual Meeting Reinforce the Critical Role of Germline Genetic Testing in Oncology
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced nine studies to be presented at the 2023 American Society of Clinical...
Source: prnewswire.com
Understanding Lynch Syndrome and Associated Cancer Risk: Identification
In this third episode of OncChats: Understanding Lynch Syndrome and Cancer Risk, Fay Kastrinos, MD, MPH, discusses testing guidance for identifying Lynch syndrome.
Source: onclive.com
Practical Considerations for Managing RR DTC With Systemic Therapy
Comprehensive insight on best practices in dose adjustment and adverse event management in patients receiving systemic therapy for RR DTC.
Source: onclive.com